116 related articles for article (PubMed ID: 16258923)
1. A QSAR for the mutagenic potencies of twelve 2-amino-trimethylimidazopyridine isomers: structural, quantum chemical, and hydropathic factors.
Knize MG; Hatch FT; Tanga MJ; Lau EY; Colvin ME
Environ Mol Mutagen; 2006 Mar; 47(2):132-46. PubMed ID: 16258923
[TBL] [Abstract][Full Text] [Related]
2. Structural and quantum chemical factors affecting mutagenic potency of aminoimidazo-azaarenes.
Hatch FT; Colvin ME; Seidl ET
Environ Mol Mutagen; 1996; 27(4):314-30. PubMed ID: 8665874
[TBL] [Abstract][Full Text] [Related]
3. Mutagenic potency of food-derived heterocyclic amines.
Felton JS; Knize MG; Wu RW; Colvin ME; Hatch FT; Malfatti MA
Mutat Res; 2007 Mar; 616(1-2):90-4. PubMed ID: 17161439
[TBL] [Abstract][Full Text] [Related]
4. Quantitative structure-activity (QSAR) relationships of mutagenic aromatic and heterocyclic amines.
Hatch FT; Colvin ME
Mutat Res; 1997 May; 376(1-2):87-96. PubMed ID: 9202742
[TBL] [Abstract][Full Text] [Related]
5. Structure-mutagenicity study of 12 trimethylimidazopyridine isomers using orbital energies and "spectrum-like representation" as descriptors.
Vraćko M; Szymoszek A; Barbieri P
J Chem Inf Comput Sci; 2004; 44(2):352-8. PubMed ID: 15032511
[TBL] [Abstract][Full Text] [Related]
6. Ultimate carcinogenic metabolites from aromatic and heterocyclic aromatic amines: a computational study in relation to their mutagenic potency.
Borosky GL
Chem Res Toxicol; 2007 Feb; 20(2):171-80. PubMed ID: 17261035
[TBL] [Abstract][Full Text] [Related]
7. Extended quantitative structure-activity relationships for 80 aromatic and heterocyclic amines: structural, electronic, and hydropathic factors affecting mutagenic potency.
Hatch FT; Knize MG; Colvin ME
Environ Mol Mutagen; 2001; 38(4):268-91. PubMed ID: 11774358
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and decomposition of an ester derivative of the procarcinogen and promutagen, PhIP, 2-amino-1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridine: unusual nitrenium ion chemistry.
Nguyen TM; Novak M
J Org Chem; 2007 Jun; 72(13):4698-706. PubMed ID: 17542636
[TBL] [Abstract][Full Text] [Related]
9. Prediction of mutagenic activity of nitrophenanthrene and nitroanthracene isomers by simulated IR and Raman spectra.
Alparone A; Librando V
Chemosphere; 2013 Jan; 90(2):158-63. PubMed ID: 22809700
[TBL] [Abstract][Full Text] [Related]
10. Ames test and antitumor activity of 1-(X-phenyl)-3,3-dialkyltriazenes. Quantitative structure-activity studies based upon molecular shape analysis.
Hopfinger AJ; Potenzone R
Mol Pharmacol; 1982 Jan; 21(1):187-95. PubMed ID: 7132958
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic QSAR of aromatic amines: new models for discriminating between homocyclic mutagens and nonmutagens, and validation of models for carcinogens.
Benigni R; Bossa C; Netzeva T; Rodomonte A; Tsakovska I
Environ Mol Mutagen; 2007 Dec; 48(9):754-71. PubMed ID: 18008355
[TBL] [Abstract][Full Text] [Related]
12. Structure-mutagenicity relationships of four amino-imidazonaphthyridines and imidazoquinolines.
Vikse R; Hatch FT; Winter NW; Knize MG; Grivas S; Felton JS
Environ Mol Mutagen; 1995; 26(1):79-85. PubMed ID: 7641711
[TBL] [Abstract][Full Text] [Related]
13. QSAR modelling for mutagenic potency of heteroaromatic amines by optimal SMILES-based descriptors.
Toropov AA; Toropova AP; Benfenati E
Chem Biol Drug Des; 2009 Mar; 73(3):301-12. PubMed ID: 19207466
[TBL] [Abstract][Full Text] [Related]
14. Carcinogenic carbocyclic and heterocyclic aromatic amines: a DFT study concerning their mutagenic potency.
Borosky GL
J Mol Graph Model; 2008 Nov; 27(4):459-65. PubMed ID: 18799337
[TBL] [Abstract][Full Text] [Related]
15. A DFT-based quantum theoretic QSAR study of aromatic and heterocyclic sulfonamides as carbonic anhydrase inhibitors against isozyme, CA-II.
Eroglu E; Türkmen H
J Mol Graph Model; 2007 Nov; 26(4):701-8. PubMed ID: 17493855
[TBL] [Abstract][Full Text] [Related]
16. In silico screening of chemicals for bacterial mutagenicity using electrotopological E-state indices and MDL QSAR software.
Contrera JF; Matthews EJ; Kruhlak NL; Benz RD
Regul Toxicol Pharmacol; 2005 Dec; 43(3):313-23. PubMed ID: 16242226
[TBL] [Abstract][Full Text] [Related]
17. Heterocyclic amine formation and the impact of structure on their mutagenicity.
Felton JS; Knize MG; Hatch FT; Tanga MJ; Colvin ME
Cancer Lett; 1999 Sep; 143(2):127-34. PubMed ID: 10503891
[TBL] [Abstract][Full Text] [Related]
18. The effect of precision of molecular orbital descriptors on toxicity modeling of selected pyridines.
Seward JR; Cronin MT; Schultz TW
SAR QSAR Environ Res; 2002 Mar; 13(2):325-40. PubMed ID: 12071659
[TBL] [Abstract][Full Text] [Related]
19. Mutagenic potential of nitrenium ions of nitrobenzanthrones: correlation between theory and experiment.
Reynisson J; Stiborová M; Martínek V; Gamboa da Costa G; Phillips DH; Arlt VM
Environ Mol Mutagen; 2008 Oct; 49(8):659-67. PubMed ID: 18618595
[TBL] [Abstract][Full Text] [Related]
20. Quantum mechanical quantitative structure-activity relationships to avoid mutagenicity.
Holder AJ; Ye L
Dent Mater; 2009 Jan; 25(1):20-5. PubMed ID: 18584863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
